The Alaska Oculocardiac Reflex Study
Launched by ALASKA BLIND CHILD DISCOVERY · Apr 16, 2020
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Alaska Oculocardiac Reflex Study is a clinical trial that is looking at how certain eye surgeries, specifically those involving the movement of eye muscles, affect heart rate and other vital signs. This study is important because it will help doctors understand how these procedures can influence a patient's heart, especially during surgery for conditions like strabismus, where the eyes don’t properly align.
If you or a loved one is scheduled for eye surgery that involves manipulating the eye muscles, you might be eligible to participate in this study, as long as there are no other eye conditions like anophthalmia (which means having no eye). Participants will be observed during their surgery, and researchers will monitor vital signs, particularly heart rate, to gather important information. This study is currently recruiting participants of all genders and ages, so if you are interested, it may be a good opportunity to contribute to medical knowledge in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient scheduled for ocular manipulation and tension on extra ocular muscles and strabismus surgery
- Exclusion Criteria:
- • anophthalmia
About Alaska Blind Child Discovery
Alaska Blind Child Discovery is a dedicated clinical trial sponsor focused on advancing research and interventions for visually impaired children. Committed to enhancing the quality of life for these children and their families, the organization collaborates with healthcare professionals, researchers, and community stakeholders to develop innovative solutions and evidence-based practices. Through rigorous clinical trials and a patient-centered approach, Alaska Blind Child Discovery aims to uncover new therapeutic avenues, improve educational resources, and foster a supportive environment that empowers visually impaired children to thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Anchorage, Alaska, United States
Patients applied
Trial Officials
Robert W Arnold, MD
Principal Investigator
Alaska Blind Child Discovery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials